Dr. Thomas Seyfried: Sugar fuels tumors, ketones starve them

Across lung, colon, brain, breast, and other cancers, Seyfried reports the same metabolic signature: reduced mitochondrial oxidative phosphorylation and elevated fermentation, evidenced by high uptake of glucose and glutamine and release of lactic and succinic acid even in oxygen-rich conditions. This implies that restricting these fuels while maintaining normal tissue with fats and ketones can selectively disadvantage tumors.

Seyfried links chronic mitochondrial damage to a gradual shift from normal respiration to fermentation. He cites contributing factors such as highly processed carbohydrates, obesity, chronic psychological stress, poor sleep, lack of exercise, certain chemical carcinogens (e.g., microplastics, talc, asbestos), and environmental toxins. Regular exercise, fasting or caloric restriction, low-glycemic diets, and strong social ties can help preserve mitochondrial function and potentially delay or prevent tumor development.

He advocates nutritional ketosis — low carbohydrate intake, higher fats, and moderate protein — to lower blood glucose and raise ketones. Normal cells with healthy mitochondria efficiently burn ketones (a ‘super fuel’), while cancer cells cannot. In practice, he recommends using a blood glucose-ketone index (GKI ≤ 2.0) as a quantitative target to approximate a Paleolithic metabolic state, which he associates with very low historical cancer incidence.

Water-only fasts and zero-carbohydrate phases (e.g., 10–14 days of meat/fish/eggs without starches or sugars) quickly lower glucose and elevate ketones, pushing the body into nutritional ketosis. Seyfried notes that fasting is difficult but metabolically potent: it mobilizes fatty acids, generates ketone bodies, improves mitochondrial efficiency, and may enhance mental focus and resilience, echoing ancient religious fasting practices.

Rather than rejecting standard care outright, Seyfried’s group in Turkey has shown that being in deep nutritional ketosis (low GKI) can increase the effectiveness of chemotherapy at reduced dosages, potentially lowering toxicity. For brain tumors, he argues that pre-operative metabolic therapy can shrink and circumscribe tumors, enabling more complete surgical debulking, and that post-operative metabolic pressure can slow or prevent recurrence.